Gilead Sciences, Inc. · NASDAQ:GILD

Kramer Kelly A. sold 10,376 Gilead Sciences, Inc. shares (Form 4)

Traded Nov 12, 2026 · Filed Nov 16, 2026

On Nov 12, 2026, Kramer Kelly A. (Director) sold 10,376 Gilead Sciences, Inc. shares at an average US$169.76 for US$1.76M under a trading plan, leaving 1,339 shares. Filed Nov 16, 2026 (Form 4).

Sold
10,376 shares
Price
US$169.76 average (US$168.23 to US$171.44)
Value
US$1.76M
Holding after
1,339 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 12, 2026Common StockOption exercise10,376US$66.9211,715Direct
Nov 12, 2026Common StockSale1,676US$168.2310,039Direct
Nov 12, 2026Common StockSale3,800US$169.446,239Direct
Nov 12, 2026Common StockSale4,700US$170.491,539Direct
Nov 12, 2026Common StockSale200US$171.441,339Direct

Source

Download original · View original at SEC

Related